NMDA reduces Tau phosphorylation in rat hippocampal slices by targeting NR2A receptors, GSK3 β, and PKC activities

Neural Plasticity

Volumn 2013, Issue , 2013, Pages

  De Montigny, Audrée ^a   Elhiri, Ismaël ^a   Allyson, Julie ^a   Cyr, Michel ^a   Massicotte, Guy ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; PROTEIN KINASE C; TAU PROTEIN; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; AMINO ACID RECEPTOR STIMULATING AGENT; BLOCKING ANTIBODY; CALCIUM; CHROMONE DERIVATIVE; EPITOPE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MORPHOLINE DERIVATIVE; N METHYL D ASPARTATE RECEPTOR SUBTYPE 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYLASPARTIC ACID; N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL DEATH; HIPPOCAMPUS; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; IN VITRO STUDY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BLOCKING; BLOTTING, WESTERN; CALCIUM; CHROMONES; ENZYME ACTIVATION; EPITOPES; EXCITATORY AMINO ACID AGONISTS; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; MORPHOLINES; N-METHYLASPARTATE; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TAU PROTEINS;

EID: 84890094411     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2013/261593     Document Type: Article

References (57)

1. Papadia S., Hardingham G. E., The dichotomy of NMDA receptor signaling. The Neuroscientist 2007 13 6 572 579 2-s2.0-35948937549 10.1177/ 10738584070130060401 (Pubitemid 350077306)
2. Hardingham G. E., Bading H., The Yin and Yang of NMDA receptor signalling. Trends in Neurosciences 2003 26 2 81 89 2-s2.0-0037301661 10.1016/S0166-2236(02)00040-1 (Pubitemid 36110542)
3. Hetman M., Kharebava G., Survival signaling pathways activated by NMDA receptors. Current Topics in Medicinal Chemistry 2006 6 8 787 799 2-s2.0-33646576836 10.2174/156802606777057553
4. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vöckler J., Dikranian K., Tenkova T. I., Stefovska V., Turski L., Olney J. W., Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999 283 5398 70 74 2-s2.0-0032947526 10.1126/science.283.5398.70 (Pubitemid 29044848)
5. Farinelli M., Heitz F. D., Grewe B. F., Tyagarajan S. K., Helmchen F., Mansuy I. M., Selective regulation of NR2B by protein phosphatase-1 for the control of the NMDA receptor in neuroprotection. PLoS ONE 2012 7 3 2-s2.0-84859138345 10.1371/journal.pone.0034047 e34047
6. Scheetz A. J., Nairn A. C., Constantine-Paton M., NMDA receptor-mediated control of protein synthesis at developing synapses. Nature Neuroscience 2000 3 3 211 216 2-s2.0-0034005882 10.1038/72915 (Pubitemid 30140781)
7. Sutton M. A., Ito H. T., Cressy P., Kempf C., Woo J. C., Schuman E. M., Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. Cell 2006 125 4 785 799 2-s2.0-33646504383 10.1016/j.cell.2006.03.040
8. Wang C.-C., Held R. G., Chang S.-C., Yang L., Delpire E., Ghosh A., Hall B. J., A critical role for GluN2B-containing NMDA receptors in cortical development and function. Neuron 2011 72 5 789 805 2-s2.0-83255194576 10.1016/j.neuron.2011.09.023
9. Fiumelli H., Riederer I. M., Martin J.-L., Riederer B. M., Phosphorylation of neurofilament subunit NF-M is regulated by activation of NMDA receptors and modulates cytoskeleton stability and neuronal shape. Cell Motility and the Cytoskeleton 2008 65 6 495 504 2-s2.0-44849092892 10.1002/cm.20278 (Pubitemid 351794105)
10. Baird D. H., Trenkner E., Mason C. A., Arrest of afferent axon extension by target neurons in vitro is regulated by the NMDA receptor. The Journal of Neuroscience 1996 16 8 2642 2648 2-s2.0-0029864167 (Pubitemid 26124351)
11. Quinlan E. M., Halpain S., Postsynaptic mechanisms for bidirectional control of MAP2 phosphorylation by glutamate receptors. Neuron 1996 16 2 357 368 2-s2.0-0030069916 10.1016/S0896-6273(00)80053-7 (Pubitemid 26072368)
12. Llansola M., Sáez R., Felipo V., NMDA-induced phosphorylation of the microtubule-associated protein MAP-2 is mediated by activation of nitric oxide synthase and MAP kinase. The European Journal of Neuroscience 2001 13 7 1283 1291 2-s2.0-0035061987 10.1046/j.0953-816X.2001.01497.x (Pubitemid 32328482)
13. Fleming L. M., Johnson G. V. W., Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. The Biochemical Journal 1995 309 1 41 47 2-s2.0-0029072567
14. Wang J.-Z., Liu F., Microtubule-associated protein tau in development, degeneration and protection of neurons. Progress in Neurobiology 2008 85 2 148 175 2-s2.0-43249124363 10.1016/j.pneurobio.2008.03.002
15. Mandelkow E. M., Mandelkow E., Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harbor Perspectives in Medicine 2012 2 a006247
16. Morris M., Maeda S., Vossel K., Mucke L., The many faces of tau. Neuron 2011 70 3 410 426 2-s2.0-79955670132 10.1016/j.neuron.2011.04.009
17. Gendron T. F., The role of tau in neurodegeneration. Molecular Neurodegeneration 2009 4 1, article 13 2-s2.0-63849176138 10.1186/1750-1326-4-13
18. Köhr G., NMDA receptor function: subunit composition versus spatial distribution. Cell and Tissue Research 2006 326 2 439 446 2-s2.0-33748921093 10.1007/s00441-006-0273-6 (Pubitemid 44435819)
19. Berberich S., Jensen V., Hvalby Ø., Seeburg P. H., Köhr G., The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. Neuropharmacology 2007 52 1 77 86 2-s2.0-33845906327 10.1016/j.neuropharm.2006. 07.016 (Pubitemid 46026830)
20. Wenzel A., Fritschy J. M., Mohler H., Benke D., NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. Journal of Neurochemistry 1997 68 2 469 478 2-s2.0-0031012513 (Pubitemid 27044705)
21. Sanz-Clemente A., Nicoll R. A., Roche K. W., Diversity in NMDA receptor composition: many regulators, many consequences. The Neuroscientist 2013 19 1 62 75 10.1177/1073858411435129
22. Cull-Candy S., Brickley S., Farrant M., NMDA receptor subunits: diversity, development and disease. Current Opinion in Neurobiology 2001 11 3 327 335 2-s2.0-0035369112 10.1016/S0959-4388(00)00215-4 (Pubitemid 32524098)
23. Liu Z., Lv C., Zhao W., Song Y., Pei D., Xu T., NR2B-containing NMDA receptors expression and their relationship to apoptosis in hippocampus of Alzheimer's disease-like rats. Neurochemical Research 2012 37 7 1420 1427 2-s2.0-84857131872 10.1007/s11064-012-0726-0
24. Liu Y., Tak P. W., Aarts M., Rooyakkers A., Liu L., Ted W. L., Dong C. W., Lu J., Tymianski M., Craig A. M., Yu T. W., NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. The Journal of Neuroscience 2007 27 11 2846 2857 2-s2.0-33947331063 10.1523/JNEUROSCI.0116-07.2007 (Pubitemid 46438991)
25. Choo A. M., Geddes-Klein D. M., Hockenberry A., Scarsella D., Mesfin M. N., Singh P., Patel T. P., Meaney D. F., NR2A and NR2B subunits differentially mediate MAP kinase signaling and mitochondrial morphology following excitotoxic insult. Neurochemistry International 2012 60 5 506 516 2-s2.0-84857950132 10.1016/j.neuint.2012.02.007
26. Allyson J., Dontigny E., Auberson Y., Cyr M., Massicotte G., Blockade of NR2A-containing NMDA receptors induces tau phosphorylation in rat hippocampal slices. Neural Plasticity 2010 2010 2-s2.0-77953503045 10.1155/2010/340168 340168
27. Lan J.-Y., Skeberdis V. A., Jover T., Grooms S. Y., Lin Y., Araneda R. C., Zheng X., Bennett M. V. L., Zukin R. S., Protein kinase C modulates NMDA receptor trafficking and gating. Nature Neuroscience 2001 4 4 382 390 2-s2.0-0035094057 10.1038/86028 (Pubitemid 32260114)
28. Jones M. L., Liao G.-Y., Malecki R., Li M., Salazar N. M., Leonard J. P., PI 3-kinase and PKC ζ mediate insulin-induced potentiation of NMDA receptor currents in Xenopus oocytes. Brain Research 2012 1432 7 14 2-s2.0-84655165030 10.1016/j.brainres.2011.11.020
29. Buée L., Bussière T., Buée-Scherrer V., Delacourte A., Hof P. R., Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Research Reviews 2000 33 1 95 130 2-s2.0-0033850407 10.1016/S0165-0173(00)00019-9
30. Maurage C.-A., Sergeant N., Ruchoux M.-M., Hauw J.-J., Delacourte A., Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology. Acta Neuropathologica 2003 105 2 89 97 2-s2.0-0037317445 (Pubitemid 36798793)
31. Avila J., Lucas J. J., Pérez M., Hernández F., Role of tau protein in both physiological and pathological conditions. Physiological Reviews 2004 84 2 361 384 2-s2.0-1642289188 10.1152/physrev.00024.2003 (Pubitemid 38365487)
32. Waxman E. A., Lynch D. R., N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. The Neuroscientist 2005 11 1 37 49 2-s2.0-13544268511 10.1177/1073858404269012 (Pubitemid 40223089)
33. Yu J.-T., Chang R. C.-C., Tan L., Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities. Progress in Neurobiology 2009 89 3 240 255 2-s2.0-70350304571 10.1016/j.pneurobio.2009.07.009
34. George A. A., Macleod G. T., Zakon H. H., Calcium-dependent phosphorylation regulates neuronal stability and plasticity in a highly precise pacemaker nucleus. Journal of Neurophysiology 2011 106 1 319 331 2-s2.0-79959933633 10.1152/jn.00741.2010
35. Kambe Y., Nakamichi N., Takarada T., Fukumori R., Nakazato R., Hinoi E., Yoneda Y., A possible pivotal role of mitochondrial free calcium in neurotoxicity mediated by N-methyl-d-aspartate receptors in cultured rat hippocampal neurons. Neurochemistry International 2011 59 1 10 20 2-s2.0-79960152288 10.1016/j.neuint.2011.03.018
36. Hurtado D. E., Molina-Porcel L., Carroll J. C., Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease. The Journal of Neuroscience 2012 32 7392 7402
37. Plattner F., Angelo M., Giese K. P., The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. The Journal of Biological Chemistry 2006 281 35 25457 25465 2-s2.0-33748752882 10.1074/jbc.M603469200 (Pubitemid 44401934)
38. Bradley C. A., Peineau S., Taghibiglou C., Nicolas C. S., Whitcomb D. J., Bortolotto Z. A., Kaang B.-K., Cho K., Wang Y. T., Collingridge G. L., A pivotal role of GSK-3 in synaptic plasticity. Frontiers in Molecular Neuroscience 2012 5 13 2-s2.0-84857219616
39. Song B., Lai B., Zheng Z., Zhang Y., Luo J., Wang C., Chen Y., Woodgett J. R., Li M., Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. The Journal of Biological Chemistry 2010 285 52 41122 41134 2-s2.0-78650367828 10.1074/jbc.M110.130351
40. Ortega F., Pérez-Sen R., Morente V., Delicado E. G., Miras-Portugal M. T., P2X7, NMDA and BDNF receptors converge on GSK3 phosphorylation and cooperate to promote survival in cerebellar granule neurons. Cellular and Molecular Life Sciences 2010 67 10 1723 1733 2-s2.0-77951887802 10.1007/s00018-010-0278-x
41. Sun M. K., Alkon D. L., Activation of protein kinase C isozymes for the treatment of dementias. Advances in Pharmacology 2012 64 273 302 10.1016/B978-0-12-394816-8.00008-8
42. Nykänen N.-P., Kysenius K., Sakha P., Tammela P., Huttunen H. J., γ -aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation. The Journal of Biological Chemistry 2012 287 9 6743 6752 2-s2.0-84857476293 10.1074/jbc.M111.309385
43. Thornton T. M., Pedraza-Alva G., Deng B., Wood C. D., Aronshtam A., Clements J. L., Sabio G., Davis R. J., Matthews D. E., Doble B., Rincon M., Phosphorylation by p38 MAPK as an alternative pathway for GSK3 β inactivation. Science 2008 320 5876 667 670 2-s2.0-43249106330 10.1126/science.1156037 (Pubitemid 351928349)
44. Bullmann T., de Silva R., Holzer M., Mori H., Arendt T., Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus. Hippocampus 2007 17 2 98 102 2-s2.0-33847653807 10.1002/hipo.20255 (Pubitemid 46362604)
45. Lee V. M., Brunden K. R., Hutton M., Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harbor Perspectives in Medicine 2011 1 1 a006437
46. Voss K., Gamblin T. C., GSK-3 phosphorylation of functionally distinct tau isoforms has differential, but mild effects. Molecular Neurodegeneration 2009 4 1, article 18 2-s2.0-66249137771 10.1186/1750-1326-4-18
47. Spillantini M. G., Goedert M., Tau protein pathology in neurodegenerative diseases. Trends in Neurosciences 1998 21 10 428 433 2-s2.0-0003374626 10.1016/S0166-2236(98)01337-X (Pubitemid 28449072)
48. Mondragon-Rodriguez S., Trillaud-Doppia E., Dudilot A., Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. The Journal of Biological Chemistry 2012 287 32040 32053
49. Pooler A. M., Usardi A., Evans C. J., Philpott K. L., Noble W., Hanger D. P., Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiology of Aging 2012 33 2 431.e27 431.e38 2-s2.0-82755189704 10.1016/j.neurobiolaging.2011.01.005
50. Ittner L. M., Ke Y. D., Delerue F., Bi M., Gladbach A., van Eersel J., Wölfing H., Chieng B. C., Christie M. J., Napier I. A., Eckert A., Staufenbiel M., Hardeman E., Götz J., Dendritic function of tau mediates amyloid- β toxicity in Alzheimer's disease mouse models. Cell 2010 142 3 387 397 2-s2.0-77955322042 10.1016/j.cell.2010.06.036
51. Zempel H., Thies E., Mandelkow E., Mandelkow E.-M., A β oligomers cause localized Ca2+ elevation, missorting of endogenous tau into dendrites, tau phosphorylation, and destruction of microtubules and spines. The Journal of Neuroscience 2010 30 36 11938 11950 2-s2.0-77956587739 10.1523/JNEUROSCI.2357- 10.2010
52. Hoover B. R., Reed M. N., Su J., Penrod R. D., Kotilinek L. A., Grant M. K., Pitstick R., Carlson G. A., Lanier L. M., Yuan L.-L., Ashe K. H., Liao D., Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 2010 68 6 1067 1081 2-s2.0-78650251838 10.1016/j.neuron.2010.11.030
53. Sun M.-K., Alkon D. L., Pharmacology of protein kinase C activators: cognition-enhancing and antidementic therapeutics. Pharmacology & Therapeutics 2010 127 1 66 77 2-s2.0-77953543762 10.1016/j.pharmthera.2010.03. 001
54. Alkon D. L., Sun M.-K., Nelson T. J., PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease. Trends in Pharmacological Sciences 2007 28 2 51 60 2-s2.0-33846528583 10.1016/j.tips.2006. 12.002 (Pubitemid 46161834)
55. de Barry J., Liégeois C. M., Janoshazi A., Protein kinase C as a peripheral biomarker for Alzheimer's disease. Experimental Gerontology 2010 45 1 64 69 2-s2.0-71849092119 10.1016/j.exger.2009.10.015
56. Khan T. K., Nelson T. J., Verma V. A., Wender P. A., Alkon D. L., A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses A β -induced biomarker abnormality on cultured fibroblasts. Neurobiology of Disease 2009 34 2 332 339 2-s2.0-64449084409 10.1016/j.nbd.2009.02.003
57. Bi X., Alzheimer disease: updateon basic mechanisms. The Journal of the American Osteopathic Association 2010 110 9 S3 S9 2-s2.0-78651380121